Entry |
|
Symbol |
ADCY5
|
Name |
(RefSeq) adenylate cyclase type 5 isoform X1
|
KO |
|
Organism |
mlk Mustela lutreola (European mink)
|
Pathway |
mlk04072 | Phospholipase D signaling pathway |
mlk04213 | Longevity regulating pathway - multiple species |
mlk04261 | Adrenergic signaling in cardiomyocytes |
mlk04270 | Vascular smooth muscle contraction |
mlk04723 | Retrograde endocannabinoid signaling |
mlk04750 | Inflammatory mediator regulation of TRP channels |
mlk04914 | Progesterone-mediated oocyte maturation |
mlk04923 | Regulation of lipolysis in adipocytes |
mlk04925 | Aldosterone synthesis and secretion |
mlk04927 | Cortisol synthesis and secretion |
mlk04928 | Parathyroid hormone synthesis, secretion and action |
mlk04935 | Growth hormone synthesis, secretion and action |
mlk05163 | Human cytomegalovirus infection |
mlk05166 | Human T-cell leukemia virus 1 infection |
mlk05207 | Chemical carcinogenesis - receptor activation |
|
Brite |
KEGG Orthology (KO) [BR:mlk00001]
09100 Metabolism
09104 Nucleotide metabolism
00230 Purine metabolism
131824632 (ADCY5)
09130 Environmental Information Processing
09132 Signal transduction
04015 Rap1 signaling pathway
131824632 (ADCY5)
04371 Apelin signaling pathway
131824632 (ADCY5)
04072 Phospholipase D signaling pathway
131824632 (ADCY5)
04024 cAMP signaling pathway
131824632 (ADCY5)
04022 cGMP-PKG signaling pathway
131824632 (ADCY5)
09133 Signaling molecules and interaction
04082 Neuroactive ligand signaling
131824632 (ADCY5)
04081 Hormone signaling
131824632 (ADCY5)
09140 Cellular Processes
09143 Cell growth and death
04114 Oocyte meiosis
131824632 (ADCY5)
09144 Cellular community - eukaryotes
04540 Gap junction
131824632 (ADCY5)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
131824632 (ADCY5)
04062 Chemokine signaling pathway
131824632 (ADCY5)
09152 Endocrine system
04911 Insulin secretion
131824632 (ADCY5)
04923 Regulation of lipolysis in adipocytes
131824632 (ADCY5)
04912 GnRH signaling pathway
131824632 (ADCY5)
04913 Ovarian steroidogenesis
131824632 (ADCY5)
04915 Estrogen signaling pathway
131824632 (ADCY5)
04914 Progesterone-mediated oocyte maturation
131824632 (ADCY5)
04921 Oxytocin signaling pathway
131824632 (ADCY5)
04926 Relaxin signaling pathway
131824632 (ADCY5)
04935 Growth hormone synthesis, secretion and action
131824632 (ADCY5)
04918 Thyroid hormone synthesis
131824632 (ADCY5)
04928 Parathyroid hormone synthesis, secretion and action
131824632 (ADCY5)
04916 Melanogenesis
131824632 (ADCY5)
04924 Renin secretion
131824632 (ADCY5)
04925 Aldosterone synthesis and secretion
131824632 (ADCY5)
04927 Cortisol synthesis and secretion
131824632 (ADCY5)
09153 Circulatory system
04261 Adrenergic signaling in cardiomyocytes
131824632 (ADCY5)
04270 Vascular smooth muscle contraction
131824632 (ADCY5)
09154 Digestive system
04970 Salivary secretion
131824632 (ADCY5)
04971 Gastric acid secretion
131824632 (ADCY5)
04972 Pancreatic secretion
131824632 (ADCY5)
04976 Bile secretion
131824632 (ADCY5)
09156 Nervous system
04724 Glutamatergic synapse
131824632 (ADCY5)
04727 GABAergic synapse
131824632 (ADCY5)
04725 Cholinergic synapse
131824632 (ADCY5)
04728 Dopaminergic synapse
131824632 (ADCY5)
04726 Serotonergic synapse
131824632 (ADCY5)
04723 Retrograde endocannabinoid signaling
131824632 (ADCY5)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
131824632 (ADCY5)
09149 Aging
04211 Longevity regulating pathway
131824632 (ADCY5)
04213 Longevity regulating pathway - multiple species
131824632 (ADCY5)
09159 Environmental adaptation
04713 Circadian entrainment
131824632 (ADCY5)
04714 Thermogenesis
131824632 (ADCY5)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
131824632 (ADCY5)
05207 Chemical carcinogenesis - receptor activation
131824632 (ADCY5)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
131824632 (ADCY5)
05163 Human cytomegalovirus infection
131824632 (ADCY5)
09164 Neurodegenerative disease
05012 Parkinson disease
131824632 (ADCY5)
09165 Substance dependence
05030 Cocaine addiction
131824632 (ADCY5)
05031 Amphetamine addiction
131824632 (ADCY5)
05032 Morphine addiction
131824632 (ADCY5)
05034 Alcoholism
131824632 (ADCY5)
09166 Cardiovascular disease
05414 Dilated cardiomyopathy
131824632 (ADCY5)
09167 Endocrine and metabolic disease
04934 Cushing syndrome
131824632 (ADCY5)
09176 Drug resistance: antineoplastic
01522 Endocrine resistance
131824632 (ADCY5)
Enzymes [BR:mlk01000]
4. Lyases
4.6 Phosphorus-oxygen lyases
4.6.1 Phosphorus-oxygen lyases (only sub-subclass identified to date)
4.6.1.1 adenylate cyclase
131824632 (ADCY5)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
2:complement(103427361..103574235)
|
AA seq |
1262 aa
MSGSKSVSPPGYAAQTAAAPASRGGPEHRSAWGEADSRANGYPHAPGGSTRGCTKKPGGA
VTPQQQQQQRLANRWRSDDDDDDPPLSGDDPLAGGFGFSFRSKSAWQERGGDDCGRGSRR
QRRGAAGGGSTRAPPAGGGGGSAAAAAAAGGTEVRPRSVELGLEERRGKGRAVDELEAGA
VEGDEGSGDGGSSAESGAGPGAVLSLGACCLALLQIFRSKKFPSDKLERLYQRYFFRLNQ
SSLTMLMAVLVLVCLVMLAFHAARPPLQLPYLAVLAAAVGVILVMAVLCNRAAFHQDHMG
LACYALIAVVLAVQVVGLLLPQPRSASEGIWWTVFFIYTIYTLLPVRMRAAVLSGVLLSA
LHLAIALRTNAQDQFLLKQLVSNVLIFSCTNIVGVCTHYPAEVSQRQAFQETRECIQARL
HSQRENQQQERLLLSVLPRHVAMEMKADINAKQEDMMFHKIYIQKHDNVSILFADIEGFT
SLASQCTAQELVMTLNELFARFDKLAAENHCLRIKILGDCYYCVSGLPEARADHAHCCVE
MGMDMIEAISLVREVTGVNVNMRVGIHSGRVHCGVLGLRKWQFDVWSNDVTLANHMEAGG
KAGRIHITKATLNYLNGDYEVEPGCGGERNAYLKEHSIETFLILRCTQKRKEEKAMIAKM
NRQRTNSIGHNPPHWGAERPFYNHLGGNQVSKEMKRMGFEDPKDKNAQESANPEDEVDEF
LGRAIDARSIDRLRSEHVRKFLLTFREPDLEKKYSKQVDDRFGAYVACASLVFLFICFVQ
ITIMPHSVFMLSFYLTCFLLLTLVVFVSVIYSCVKLFPTPLQTLSRKIVRSKMNSTLVGV
FTITLVFLSAFVNMFTCNSENLLGCLADEHNISTGQVNACHVVASASNYSLGADQGFCRS
PWPSCNFPEYFTYSVLLSLLACSVFLQISCIGKLVLMLAIELTYVLIVEVPRVTLFDNAD
LLVTANAIDFNNNGTSQCPEHATKVALKVVTPIIISVFVLALYLHAQQVESTARLDFLWK
LQATEEKEEMEELQAYNRRLLHNILPKDVAAHFLARERRNDELYYQSCECVAVMFASIAN
FSEFYVELEANNEGVECLRLLNEIIADFDEIISEDRFRQLEKIKTIGSTYMAASGLNDST
YDKVGKSHIKALADFAMKLMDQMKYINEHSFNNFQMKIGLNIGPVVAGVIGARKPQYDIW
GNTVNVASRMDSTGVPDRIQVTTDMYQVLAANTYQLECRGVVKVKGKGEMMTYFLNGGPP
LS |
NT seq |
3789 nt +upstreamnt +downstreamnt
atgtccggctccaaaagcgtgagccccccgggctacgcggcgcagacagctgctgcgccg
gcgtcccggggaggcccggaacaccgctcggcgtggggggaggcggattcccgcgccaat
ggctacccccacgctcccgggggttcgacccgcggctgcaccaagaaacccgggggggcg
gtgaccccgcagcagcagcagcagcagcgcttggctaaccgctggcgcagcgacgacgac
gacgacgatcctccgctgagcggcgacgaccccctggccgggggcttcggcttcagtttc
cgctccaagtcggcctggcaggagcgcggcggcgacgactgcggtcgcggcagccgccgg
cagcggcggggcgcggccggcgggggcagcacccgggcgccccctgcgggcggcggtggc
ggctcggcggcggcggcggcagcggccggcgggacggaggtgcgccctcgctcggtggag
ctgggcctggaggagcggcggggcaagggccgcgcggtggacgaactggaggccggcgcc
gtcgagggcgacgaaggatctggggatggcggcagctcggcagaatcgggtgcggggccc
ggcgcagtgctgtcgctgggcgcctgctgcctggcgctgctgcagatattccgctccaag
aagttcccgtcggacaagctggagcggctgtaccagcgctacttcttccgtctgaaccag
agcagcctcactatgctcatggccgtgctggtgctcgtgtgcctcgtcatgttggccttc
cacgcggcgcggcccccgctccagctgccctacctggcagtgctggcggctgcggtaggt
gtcatcctcgtcatggctgtgctctgcaaccgcgccgccttccaccaggaccacatgggc
ctggcctgctacgcgctcatcgccgtcgtgctggccgtccaggtggtgggcctgctgctg
ccccagccacgcagcgcctcggagggcatctggtggaccgtgttcttcatctacaccatc
tacacgttgctgcctgtgcgcatgcgtgccgcggtactcagcggagtgctcctgtctgcc
ctccacctggccatagccctgcgcaccaacgcccaggaccagttcctgctcaagcagctt
gtctccaatgtcctcattttctcctgcaccaacatcgtgggtgtctgcacccactacccg
gctgaggtctcccagagacaggccttccaggagacccgggagtgcatccaggcacgactc
cactcacaacgggagaaccagcaacaggagcggctcctgctgtctgtcctgccccgtcat
gttgccatggagatgaaagcagacatcaatgccaagcaggaggatatgatgttccataag
atttacatccagaaacatgacaacgtgagcatcctgtttgccgacatcgagggcttcacc
agcctggcatcccagtgcactgcccaggagctggtcatgaccctcaacgagctcttcgcc
cgctttgacaagctggctgcggagaatcactgtttacgtattaagatcctgggggattgc
tattactgtgtctctgggctgccggaagcgagggctgaccatgcccactgctgcgtggag
atgggcatggacatgattgaggccatctcgttggtccgggaggtgacaggggtgaacgtg
aacatgcgcgtgggaattcacagcgggcgagtacactgcggtgtccttggtctcaggaag
tggcagttcgacgtctggtctaatgacgtcacgctggccaaccacatggaagctggaggc
aaggcagggcgtatccacatcaccaaggccacactcaactacctgaatggggactacgag
gtggagccgggctgtgggggcgagcgcaacgcctacctcaaggagcacagtatcgagacc
ttcctcatcctgcgctgtacccagaagcggaaagaagaaaaggccatgattgccaagatg
aatcgccagagaaccaactccatcgggcacaacccaccccactggggggccgagcgtccc
ttctacaaccacctggggggcaaccaggtgtccaaggagatgaagcggatgggcttcgaa
gaccccaaggacaagaatgcccaagaaagtgcaaaccctgaggatgaagtggacgagttt
ctgggccgcgccattgacgccaggagcatcgacaggctgcggtctgagcatgtccgcaag
ttcctcttgaccttcagggagcctgacttagagaagaagtactccaagcaggtggatgac
cgattcggtgcctacgtggcctgtgcctcgcttgtcttcctcttcatctgctttgtccaa
atcaccatcatgccccactccgtgttcatgttgagtttctacctgacctgtttcctgctg
ctgacgttggtggtatttgtgtccgtgatctactcctgcgtgaagctcttcccaacccca
ctgcagaccctctccaggaagatcgtgaggtccaagatgaacagcactctggtcggcgtg
ttcaccatcaccctcgtgttcctgtcggctttcgtcaacatgttcacgtgtaactcagag
aacctgctgggctgcctggcagacgagcacaacatcagcaccggccaggtcaacgcgtgc
catgtggtggcgtcggcctccaactacagcctgggggccgaccagggcttctgccgcagc
ccgtggcccagctgcaacttccctgagtacttcacctacagcgtgctgctcagcctgctg
gcctgctccgtgttcctgcagatcagctgcatcgggaagctggtgctcatgctggccatt
gagctcacatacgtgctcatcgttgaggtgccccgtgtcacactctttgacaatgctgac
ctgctggtcaccgccaatgccatagacttcaacaacaacgggacctcccagtgccccgag
catgcgaccaaggtggcgctgaaggtggtgacgcccatcatcatctcggtgttcgtgctg
gccctgtacctgcatgcccagcaagtggagtccaccgcccgcctggacttcctctggaaa
ctgcaggccaccgaggagaaggaggagatggaggagctgcaggcctacaacaggcggctg
ctgcacaacatcctgcccaaggacgtggccgcccacttcctggcccgcgagcggcgcaac
gacgagctctactaccagtcgtgcgagtgtgtggccgtcatgttcgcctccatcgccaac
ttctctgagttctacgtggagctggaggccaacaatgagggcgttgagtgcctgcggctg
ctcaatgagatcattgccgactttgacgagatcatcagcgaggatcggttcaggcagctg
gaaaagatcaagaccattggcagcacctacatggccgcctcaggcctcaatgactctaca
tacgacaaggtgggcaagagccacatcaaagccctggccgactttgccatgaagctcatg
gaccaaatgaagtacatcaacgaacactccttcaacaacttccagatgaagattgggctc
aacatcggccctgtggtggctggggtgatcggggctcgcaagcctcagtacgacatctgg
ggcaatacggtgaacgtggccagccgcatggacagcaccggtgtgcctgaccgcatccag
gtcaccacggacatgtaccaggtactggctgccaacacttaccagctggagtgcaggggt
gtggtcaaggtcaagggcaaaggcgagatgatgacctacttcctcaacggggggcccccg
ctcagttag |